NASDAQ · CNTB
Connect Biopharma Holdings Limited
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for CNTB: Nov 11, 2026
Connect Biopharma Holdings Limited Ordinary Shares is estimated to report earnings on 11/11/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 3 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.27. The reported EPS for the same quarter last year was $-0.31.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.27 | $-0.24 | $-0.32 | 3 |
| Dec 2026 | $-0.19 | $-0.15 | $-0.25 | 3 |
| Mar 2027 | $-0.30 | $-0.30 | $-0.30 | 1 |
| Jun 2027 | $-0.33 | $-0.33 | $-0.33 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · MarketBeat · RTTNews- Zacks · Oct 22, 8:35 AM EDTDown 25.4% in 4 Weeks, Here's Why Connect Biopharma Holdings (CNTB) Looks Ripe for a TurnaroundConnect Biopharma Holdings (CNTB) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
- Zacks · Oct 19, 8:55 AM EDTHere's Why Connect Biopharma Holdings (CNTB) Could be Great Choice for a Bottom FisherConnect Biopharma Holdings (CNTB) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
- MarketBeat · Oct 4, 3:02 AM EDTConnect Biopharma COPD Study Shows 81% Cut in Treatment FailuresConnect Biopharma (NASDAQ:CNTB) reported top-line results from its Seabreeze STAT Phase II study of rademikibart in patients experiencing acute exacerbations of chronic obstructive pulmonary disease, or COPD. The company said the study met its primary objective, showing reduction
- RTTNews · Sep 30, 2:49 PM EDTBiotech Stocks Surge – NIVF +124%, CNTB +124%, SGMT +9%, VBIO +12%, AEON(RTTNews) – Several biotech and healthcare stocks moved sharply higher on September 30, 2026, following company-specific developments including clinical data, financing activity and regulatory updates.
- RTTNews · Sep 30, 7:46 AM EDTConnect Biopharma Reports Positive Phase 2 Rademikibart Data In Acute COPD(RTTNews) – On Wednesday, Connect Biopharma Holdings Limited (CNTB) reported positive preliminary topline results from its global Phase 2 Seabreeze STAT COPD study evaluating rademikibart as an add-on treatment for acute exacerbations in adults with COPD and type 2 inflammation.
- RTTNews · Sep 30, 7:27 AM EDTConnect Biopharma Advances Rademikibart Toward Phase 3 In COPD(RTTNews) – Wednesday, Connect Biopharma Holdings (CNTB) reported positive topline results from a global Phase 2 study of rademikibart as an add-on treatment for acute exacerbations in adults with COPD and type 2 inflammation.
- RTTNews · Sep 18, 10:44 AM EDTWeekly Buzz: RARE, BAYRY Win Approvals; SION Cuts Jobs, GSK Deals; AZN, RHHBY Lead(RTTNews) – Biotech investors tracked a busy week marked by regulatory approvals, strategic collaborations, workforce restructuring and key clinical trial readouts.
- RTTNews · Sep 15, 7:27 AM EDTConnect Biopharma Reports Positive Phase 2 Data For Rademikibart In Acute Asthma Exacerbations(RTTNews) – Connect Biopharma Holdings Limited (CNTB), a clinical-stage biopharmaceutical company focused on inflammatory diseases, announced positive preliminary topline data from its global Phase 2 Seabreeze STAT Asthma study evaluating rademikibart as an add-on treatment for a
- RTTNews · Sep 3, 10:47 PM EDT6 Biotech Stocks In Focus: Modular Medical, Galmed, Pro-Dex, Connect Biopharma & More(RTTNews) – Today's after-hours gainers include Modular Medical, following FDA clearance for a series of software enhancements to its Pivot tubeless patch pump; Galmed Pharmaceuticals, after shareholders approved all five proposals presented at its annual general meeting; and Pro
- RTTNews · Sep 2, 11:20 PM EDT6 Biotech Stocks To Watch Ahead Of Key Catalysts: RenovoRx, Eupraxia, Connect Bio, Kardigan & More(RTTNews) – Today, we bring you a list of six stocks to watch in the coming days and months. Each company has potentially market-moving catalysts on the horizon, ranging from clinical data readouts and investor conference presentations to key FDA decisions. These binary events ca
- RTTNews · Jul 9, 10:50 PM EDTTop Biotech Gainers: VRAX Jumps 100% After Fosun Deal, FBRX Soars On Vitiligo Data, TRAX On Watch(RTTNews) – Today's top biotech gainers include Virax Biolabs, following its agreement with Fosun Diagnostics; Forte Biosciences, after reporting positive vitiligo data; Connect Biopharma, with a key near-term catalyst ahead; and SANUWAVE Health, despite recently lowering its sec
- RTTNews · Jun 18, 3:31 AM EDTConnect Enrolls 160 Patients In Phase 2 Trial For Rademikibart In Asthma; Topline Data In Sep '26(RTTNews) – Connect Biopharma Holdings Limited (CNTB), a clinical-stage biopharmaceutical company, on Wednesday announced completion of enrollment in the Phase 2 SEABREEZE Stat trial evaluating Rademikibart for treating acute exacerbation of asthma and type 2 inflammation. Rade
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Connect Biopharma Holdings Limited from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.